Greenphire and Mytrus Partner to Provide Web-Based Solutions for Patient Recruitment and Retention
Greenphire, based in suburban Philadelphia, and San Francisco startup Mytrus Inc. have developed web-based solutions to streamline the tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management, and communication platform, compliments the functionality offered by Mytrus and its methods for allowing patients to participate in clinical research studies from their homes.
Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development. Mytrus allows patients to use web technology to provide their own study data over the Internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.
Greenphire’s patent-pending ClinCard technology offers a fully configurable, web-based patient payment, management, and communication engine, enabling sponsor and site administrators to deliver study-specific messaging programs executed by text, email, and voice messages while delivering patient stipends, managing patient travel arrangements, and providing travel reimbursements in a controlled and automated real-time environment. The ClinCard’s functionality is in compliance with industry regulation and implemented according to the requirements of each specific study protocol. The ClinCard System has been proven to drive increased site and patient satisfaction, reduced site and sponsor administration, increased patient retention, increased protocol compliance, and reduced regulatory risk for the sponsor.
Mytrus’model uses web-based tools for recruiting and managing patients from a single remote site in San Francisco. Mytrus studies feature Greenphire’s ClinCard technology to deliver real-time stipend and reimbursement payments to their study participants. Patients receive a ClinCard immediately upon study enrollment and then receive milestone payments as they progress through a study.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
